Week of June 22, 2026 · 11 stocks
Memory's 'hundred-year flood' and a Nasdaq-100 reshuffle run the feed — while Midjourney detours into ultrasound
Memory and AI-infrastructure names dominated the conversation again, an index rebalance pulled three semis along for the ride, and an image-generator's hardware pivot lit up a medical-device stock nobody had on their card.
A million-plus mentions across an 1,101-name universe, and the texture barely changed from last week: the loudest threads were about memory pricing, AI interconnect, and who's about to get bought by passive funds. Five names join the Nasdaq-100 before Monday's open, the memory complex printed fresh records into Micron's Tuesday earnings, and the week's oddest catalyst — Midjourney building an ultrasound scanner — handed Butterfly Network a 56% day. Here's what the crowd actually talked about, ticker by ticker.
Sandisk logged 5,900 posts (up 12.7% day over day) as the NAND spin-out kept printing all-time highs above $2,100 — a roughly 4,500% move over twelve months. The fuel this week was Tim Cook telling the WSJ that a 'hundred-year flood' in memory costs may force Apple price hikes, read on X as outside validation that flash is structurally short.
Positioning is lopsidedly long, with posters name-dropping Tepper and Druckenmiller as having opened positions earlier this year. The dissent is narrow but loud: a monthly RSI of 99, described as the most overbought reading the tape has on record, plus a triple bearish divergence.
The numbers explain the zeal — Q3 revenue jumped 251% to $5.95B at a 78% gross margin, against 26% a year ago, and management guided Q4 to $7.75–$8.25B with an $11B-plus backlog. The August 13 print has to defend that guide; until then the move rests on the cycle holding.
Astera Labs drew 2,668 posts (up 15.5%) on a single mechanical catalyst: it joins the Nasdaq-100 before Monday's open alongside CoreWeave, Nebius, Rocket Lab and Teradyne, and passive funds tracking $800B-plus in assets have to buy regardless of price. The stock has already run 245% across 51 trading days into the event.
The conversation pairs genuine conviction on AI-networking — the LPO scale-up demo at Computex, accelerating Aries and Taurus demand across China, Singapore and the US — with open nerves about valuation. Posters flagged $2.71M of call-block buying at $380/$450 strikes even as they called the multiple the obvious risk.
That risk is concrete: 54x trailing sales and 60–75x forward, with two directors selling a combined $8.1M in early June, right into the index buy. Q1 grew 93% to $308M; the August 4 print is the real test of whether demand earns the multiple.
Teradyne's 735 posts (up 15.2%) ride the same Nasdaq-100 inclusion flow, but the chip-test maker brought its own catalyst stack: a co-developed Tokyo Electron solution for testing 2.5D/3D chiplet AI packages, a firm-fixed-price DoD contract, and a string of all-time-high closes after a 407% twelve-month run.
The framing on X is 'semicap-plus-robotics leader,' with chartists pointing to a textbook Stage 2 Weinstein uptrend and the stock sitting at 99% of its 52-week range.
Underneath, the operating story is best-in-class — Q1 revenue grew 87% to $1.28B at a 37% operating margin, EPS of $2.55 cleared a $2.11 consensus, the third straight beat. The asterisk is a coordinated $2.2M insider sale on June 16 just below the current price; the July 29 print decides whether the advanced-packaging tailwind keeps outrunning it.
Inter & Co posted the week's most violent acceleration — mentions up 153% day over day — as the Brazilian digital bank opened a Miami branch on June 8 and got rediscovered as a deep-value fintwit pet. The pitch writes itself in numbers: $4.44 book value against a $5.78 share price, a 9x PE on 28%-ish growth.
The bull case is explicitly relative. Posters stack it against NU, MELI and SOFI — names trading at far richer multiples for similar growth — and float a $14 target if $5.39 support holds at 200-week confluence.
The fundamentals are real: Q1 revenue grew 40% to R$4.22B, with consensus EPS scaling toward $5.98 by FY28. But the stock is down 37% year-to-date and sits at the 0.4th percentile of its range — dead on the lows — and the whole thesis carries Brazilian macro and BRL risk that the discount may simply be pricing.
Woodward is the quiet one on the list — just 36 posts, but up 21% day over day, the kind of low-base spike that flags a name entering the conversation rather than dominating it. The aerospace-and-industrial controls franchise trades at 98% of its 52-week range after gaining 81% over twelve months, with volume running 2.2x its baseline.
The recent newsflow is dense and unglamorous: a May 28 amended credit agreement extending its $1B revolver to 2031, and a June 5 8-K marking a President-level leadership transition.
The operating profile backs the rerating — Q1 revenue grew 23% to $1.09B at a 28% gross margin and 15% operating margin. The watch item is insider behavior: roughly $5.2M of option-exercise stock sales at $356 against today's $430, monetization on the run rather than open-market reduction. The July 27 print is the next checkpoint.
Micron was the week's center of gravity at 13,900 posts (up 10.9%), crossing $1,100 for the first time as the sell side stampeded ahead of Tuesday's June 24 print. The target sheet has gone parabolic — Susquehanna at $1,750, UBS tripling to $1,625, TD Cowen and Stifel near $1,500 — all anchored on HBM that Micron says is sold out through multi-year contracts.
Traders are openly chasing $1,500-plus into the print, treating Tim Cook's 'hundred-year flood' memory comment as confirmation. The bear camp is small and technical: an RSI at its most overbought in 30-plus years, and dot-com cyclical comparisons.
The fundamentals are doing what memory rarely does — Q2 revenue nearly tripled to $23.9B at a 74% gross margin, with guidance pointing to ~$33.5B and an 81% margin next. At roughly 10x FY27 EPS the math isn't stretched if the cycle holds, which is exactly what Tuesday adjudicates.
CoreWeave ran 25–30% into its Nasdaq-100 debut, drawing 3,579 posts (up 6.2%) as the neocloud poster child compressed a year of news into a week — a Cantor target hike to $167, a $99B backlog the bulls see heading to $130B, and a record DeepSeek-V3 MLPerf training run.
The thread splits cleanly. One side compares the setup to Nebius at $20; the other keeps circling the leverage — a BB-rated, off-balance-sheet bond structure and 'Jensen jail' dependence on Nvidia supply.
The data sharpens that debate. Q1 revenue grew 112% to $2.08B, but debt-to-equity sits at 3.7x and the June 18 bond raise priced at 8.5–9.6% coupons — the credit market pricing real execution risk. And named officers sold over $115M, including ~$66M from the CEO, in the same window the stock was running into forced index buying. August 11 earnings is the read.
Chagee barely registered on raw volume — three posts — but its 25% pop earned it a slot on a turnaround thesis that's gaining adherents. The premium-teahouse operator beat Q1 EPS by 39% ($0.38 vs $0.27 est), the biggest surprise in its short public life, and announced a 10% buyback.
The bull line on X is plain: the Chinese consumer model is structurally fine, overseas GMV is up 139% year over year, and the name 'still screams cheap.' A gelato pilot across nine stores in five cities gets floated as a category-test option.
The stock is still down 67% over twelve months, so this is recovery-from-the-floor, not momentum-chasing. At 17.5x earnings and an 8.7% free-cash-flow yield with comps turning positive, the multiple is defensible for a compounder mid-rerate — provided the GMV-per-store recovery, fresh after a year of declines, actually sticks.
Taiwan Semiconductor printed a fresh high near $462 and pulled 1,798 posts (up 10.4%) on a deal that hits the AI hardware bottleneck head-on: a 10-year agreement with Amkor to bring CoWoS advanced packaging to Arizona, building on a 2024 MOU and targeting a first US packaging facility by 2029.
The crowd's angle is unusual for a $2T name — it's the value call. Posters note the stock trades around 22x forward FY27 against 35% forecast revenue growth, with AMD, Nvidia and Apple all locked in as anchor customers and May revenue up 30%.
The print backs it: Q2 revenue grew 35% with a 62% gross margin, the highest the foundry has ever reported. The A14 node stays on track for 2028. The one thing no spreadsheet prices cleanly is the tail risk every TSMC holder carries — a Taiwan-China or chip-export headline. July 16 is the next read.
The week's wildcard: Butterfly Network surged 56% in a day — 791 posts, up 24.7% — after Midjourney, of all companies, unveiled a 60-second full-body ultrasound scanner built around 40 of Butterfly's Ultrasound-on-Chip modules per prototype. The image generator, it turns out, licensed Butterfly's silicon under a deal worth up to $74M over five years.
The X reaction ran straight to napkin math — 50,000 units targeted by 2031, $250–$5,000 per module, a $500M–$2B+ revenue scenario — framed as proof of an edge-AI healthcare moat.
Worth keeping the receipts in view: it's a Gen-1 prototype with no FDA clearance, starting with body-composition maps, not diagnosis. The base business grew Q1 revenue 25% to $26.5M but still runs a -51% operating margin, and the COO sold $1.9M at roughly half today's price on June 9. The volume scenarios need both an FDA pathway and CPT codes to become revenue.
Alphabet drew 6,024 posts (up 5.2%) on a rare clean-sweep week: Berkshire tripled its stake to $26.6B, and the TPU story finally read as offense rather than defense, with Citadel cited claiming 30% lower cost and 4x throughput versus Nvidia on key workloads.
The feed treats it as the cheapest mega-cap relative to growth, and the supporting list is long — a $1.5B Alabama data-center expansion, the Brazos 60kW liquid-to-air cooling rack, a $100 Gemini Home Speaker on June 25, and a $3.2B Anthropic compute guarantee at Lake Mariner.
The fundamentals keep refuting the 'search is dying' thesis: Q1 revenue grew 22% to $109.9B at a 36% operating margin, beating consensus by 94%. The hidden ballast — a 14% Anthropic stake worth $145B and 6% of SpaceX worth ~$122B — sits in almost no sum-of-parts. July 22 earnings is the next read; antitrust headlines remain the standing risk.
All eleven counts, sentiment readings and verdicts update live on TickerTalks — and the imposters we dropped this week (Litecoin trending under a sleepy REIT's symbol, a microcap squeeze borrowing the wrong name) are exactly why we read the conversation, not just the count.
Want this live, not weekly?
See what's trending right now →TickerTalks is a research tool, not financial advice. This recap describes what accounts on X are discussing — it is not a recommendation to buy or sell any security. Social attention is not predictive of future price moves; investing involves risk of loss.
